Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics
NIDA Home > Drugs of Abuse/Related Topics > Trends & Statistics > InfoFacts > Treatment Statistics

NIDA InfoFacts: Treatment Statistics

PDF Version [188K]
Printer-friendly Version
En Español

According to the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) National Survey on Drug Use and Health in 2006, 23.6 million persons aged 12 or older needed treatment for an illicit drug or alcohol abuse problem (9.6 percent of the persons aged 12 or older). Of these, only 2.5 million—10.8 percent of those who needed treatment—received it at a specialty facility.

SAMHSA also reports characteristics of admissions and discharges from substance abuse treatment facilities in their Treatment Episode Data Set (TEDS). According to TEDS, in 2006 there were nearly 1.8 million admissions for treatment of alcohol and drug abuse to facilities that report to State administrative data systems.1,2 Most admissions (40 percent) were for alcohol treatment. Heroin and other opiates accounted for the largest percentage of drug-related admissions (18 percent), followed by marijuana (16 percent).

By Drug: Admissions to Publicly Funded
Substance Abuse Treatment Programs, 2006


Percentage
of Admissions* 
Substance
or Drug
21.9 Alcohol
17.8 Alcohol + another drug
16.1 Marijuana
13.7 Heroin
9.9 Smoked cocaine (crack)
8.7 Stimulants
4.2 Opiates (not heroin) **
4.0 Other-than-smoked cocaine (e.g., cocaine powder)
0.4 Tranquilizers
0.2 PCP
0.2 Sedatives
0.1 Hallucinogens
0.1 Inhalants
0.5 Other drugs
2.4 None reported

About 59 percent of admissions were White, 21 percent were African-American, and 14 percent were Hispanic or Latino. Another 2.3 percent were Alaska Native or American Indian and 1 percent were Asian/Pacific Islander. The remaining 2 percent fell into the “Other” category.

By Race: Admissions to Publicly Funded
Substance Abuse Treatment Programs, 2006


Percentage
of Admissions 
Race/Ethinicity
59.4 White
21.3 African-American
14.0 Hispanic Origin
2.3 American Indian or Alaska Native
1.0 Asian/Pacific Islander
2.0 Other

The majority of patients entering treatment were 20–24 years old (14.4 percent), followed by those 25 to 29 (14 percent) and 40 to 44 (13.9 percent).

By Age Group: Admissions to Publicly Funded
Substance Abuse Treatment Programs, 2006


Percentage
of Admissions 
Age Group
14.4 20 – 24
14.0 25 – 29
13.9 40 – 44
13.1 35 – 39
11.3 30 – 34
11.1 45 – 49
10.4 15 – 19
9.0 50 – 59
1.3 younger than 15
1.0 60 – 64
0.6 65 or older


For other information on treatment trends, visit the Substance Abuse and Mental Health Services Administration, Office of Applied Studies Web site at www.oas.samhsa.gov or visit the National Clearinghouse for Alcohol and Drug Information at www.health.org.

For information on treatment research findings, visit the NIDA web site at www.nida.nih.gov/DrugPages/Treatment.html.



1 Includes facilities that are licensed or certified by the State substance abuse agency to provide substance abuse treatment. In general, facilities that report data are those that receive State alcohol and/or drug agency funds for the provision of alcohol and/or drug treatment services.

2 Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights – 2006. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-40, DHHS Publication No. (SMA) 08-4313, Rockville, MD.



* May add up to more than 100 percent because of rounding.

** These drugs include codeine, hydrocodone, hydromorphone, meperidine, morphine, opium, oxycodone, pentazocine, propoxyphene, tramadol, and any other drug with morphine-like effects. Non-prescription use of methadone is not included.

Revised 6/08 This page has been accessed 1141266times since 11/5/99.


Recommended Reading

Other NIDA Web Sites



NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 24, 2008. The U.S. government's official web portal